Altered gene expression in mouse livers after dichloroacetic acid exposure

Mutation Research - Reviews in Mutation Research

Volumn 543, Issue 2, 2003, Pages 167-180

  Thai, Sheau Fung ^a   Allen, James W ^a   DeAngelo, Anthony B ^a   George, Michael H ^a   Fuscoe, James C ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Dichloroacetic acid; Gene expression; Mice

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANGIOGENIN; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CARBOXYLESTERASE; CATHEPSIN D; COMPLEMENTARY DNA; CYTOCHROME P450 2C9; CYTOCHROME P450 3A1; DICHLOROACETIC ACID; DRINKING WATER; GLUTATHIONE TRANSFERASE; PLASMINOGEN; PROTHROMBIN; RNA; VITRONECTIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CELL GROWTH; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DNA MICROARRAY; DOSE CALCULATION; EXPOSURE; GENE EXPRESSION; GENETIC ANALYSIS; LIVER; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRECURSOR; PRIORITY JOURNAL; RNA ISOLATION; TIME; XENOBIOTIC METABOLISM;

ANIMALIA; RODENTIA;

EID: 0037339247     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(03)00014-0     Document Type: Article

References (56)

1. Uden D.L., Strand L.M., Miller K.W., Zaske D.E. Determination of theophylline bioavailability using saliva theophylline concentrations. Pharmacotherapy. 3:1983;235-238.
2. Fox A.W., Yang X., Murli H., Lawlor T.E., Cifone M.A., Reno F.E. Absence of mutagenic effects of sodium dichloroacetate. Fundam. Appl. Toxicol. 32:1996;87-95.
3. Fuscoe J.C., Afshari A.J., George M.H., DeAngelo A.B., Tice R.R., Salman T., Allen J.W. In vivo genotoxicity of dichloroacetic acid: evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay. Environ. Mol. Mutagen. 27:1996;1-9.
4. DeMarini D.M., Perry E., Shelton M.L. Dichloroacetic acid and related compounds: induction of prophage in E. coli and mutagenicity and mutation spectra in Salmonella TA100. Mutagenesis. 9:1994;429-437.
5. DeAngelo A.B., Daniel F.B., Stober J.A., Olson G.R. The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 16:1991;337-347.
6. DeAngelo A.B., George M.H., House D.E. Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J. Toxicol. Environ. Health A. 58:1999;485-507.
7. Bull R.J., Sanchez I.M., Nelson M.A., Larson J.L., Lansing A.J. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology. 63:1990;341-359.
8. Richmond R.E., DeAngelo A.B., Potter C.L., Daniel F.B. The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice. Carcinogenesis. 12:1991;1383-1387.
9. DeAngelo A.B., Daniel F.B., Most B.M., Olson G.R. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology. 114:1996;207-221.
10. Thai S.F., Allen J.W., DeAngelo A.B., George M.H., Fuscoe J.C. Detection of early gene expression changes by differential display in the livers of mice exposed to dichloroacetic acid. Carcinogenesis. 22:2001;1317-1322.
11. Parfyonova Y.V., Plekhanova O.S., Tkachuk V.A. Plasminogen activators in vascular remodeling and angiogenesis. Biochemistry (Moscow). 67:2002;119-134.
12. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J. Cell Mol. Med. 6:2002;1-12.
13. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., Wiegand S.J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 284:1999;1994-1998.
14. Sounni N.E., Devy L., Hajitou A., Frankenne F., Munaut C., Gilles C., Deroanne C., Thompson E.W., Foidart J.M., Noel A. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 16:2002;555-564.
15. Chang C., Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11:2001;S37-S43.
16. Takai S., Shiota N., Jin D., Miyazaki M. Functional role of chymase in angiotensin II formation in human vascular tissue. J. Cardiovasc. Pharmacol. 32:1998;826-833.
17. Waugh J.M., Li-Hawkins J., Yuksel E., Cifra P.N., Amabile P.G., Hilfiker P.R., Geske R.S., Kuo M.D., Thomas J.W., Dake M.D., Woo S.L. Therapeutic elastase inhibition by alpha-1-antitrypsin gene transfer limits neointima formation in normal rabbits. J. Vasc. Interv. Radiol. 12:2001;1203-1209.
18. Berdusco E.T., Yang K., Challis J.R., Hammond G.L. Tissue distribution of alpha 1-proteinase inhibitor messenger ribonucleic acid and its regulation by glucocorticoids in fetal and neonatal sheep. Biol. Reprod. 49:1993;816-821.
19. Shamamian P., Pocock B.J., Schwartz J.D., Monea S., Chuang N., Whiting D., Marcus S.G., Galloway A.C., Mignatti P. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion. Surgery. 127:2000;142-147.
20. Khatib A.M., Siegfried G., Prat A., Luis J., Chretien M., Metrakos P., Seidah N.G. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J. Biol. Chem. 276:2001;30686-30693.
21. Finlay T.H., Tamir S., Kadner S.S., Cruz M.R., Yavelow J., Levitz M. Alpha 1-antitrypsin- and anchorage-independent growth of MCF-7 breast cancer cells. Endocrinology. 133:1993;996-1002.
22. Yavelow J., Tuccillo A., Kadner S.S., Katz J., Finlay T.H. Alpha 1-antitrypsin blocks the release of transforming growth factor-alpha from MCF-7 human breast cancer cells. J. Clin. Endocrinol. Metab. 82:1997;745-752.
23. Shamamian P., Schwartz J.D., Pocock B.J., Monea S., Whiting D., Marcus S.G., Mignatti P. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J. Cell Physiol. 189:2001;197-206.
24. Oh J., Takahashi R., Kondo S., Mizoguchi A., Adachi E., Sasahara R.M., Nishimura S., Imamura Y., Kitayama H., Alexander D.B., Ide C., Horan T.P., Arakawa T., Yoshida H., Nishikawa S., Itoh Y., Seiki M., Itohara S., Takahashi C., Noda M. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 107:2001;789-800.
25. Pozzi A., LeVine W.F., Gardner H.A. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis. Oncogene. 21:2002;272-281.
26. Deryugina E.I., Bourdon M.A., Reisfeld R.A., Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res. 58:1998;3743-3750.
27. Deryugina E.I., Soroceanu L., Strongin A.Y. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res. 62:2002;580-588.
28. Indraccolo S., Morini M., Gola E., Carrozzino F., Habeler W., Minghelli S., Santi L., Chieco-Bianchi L., Cao Y., Albini A., Noonan D.M. Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells. Cancer Res. 61:2001;5441-5446.
29. Gyorffy S., Palmer K., Gauldie J. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice. Am. J. Pathol. 159:2001;1137-1147.
30. Rodolfo M., Cato E.M., Soldati S., Ceruti R., Asioli M., Scanziani E., Vezzoni P., Parmiani G., Sacco M.G. Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy. Cancer Gene Ther. 8:2001;491-496.
31. Morikawa W., Yamamoto K., Ishikawa S., Takemoto S., Ono M., Fukushi J., Naito S., Nozaki C., Iwanaga S., Kuwano M. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. J. Biol. Chem. 275:2000;38912-38920.
32. Cornelius L.A., Nehring L.C., Harding E., Bolanowski M., Welgus H.G., Kobayashi D.K., Pierce R.A., Shapiro S.D. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161:1998;6845-6852.
33. Badet J. Angiogenin. Pathol. Biol. (Paris). 47:1999;345-351.
34. Pavlov N., Badet J. Angiogenin: involvement in angiogenesis and tumour growth. Bull. Cancer. 88:2001;725-732.
35. Huet E., Brassart B., Cauchard J.H., Debelle L., Birembaut P., Wallach J., Emonard H., Polette M., Hornebeck W. Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells. Clin. Exp. Metastasis. 19:2002;107-117.
36. Ryniers F., Stove C., Goethals M., Brackenier L., Noe V., Bracke M., Vandekerckhove J., Mareel M., Bruyneel E. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol. Chem. 383:2002;159-165.
37. Wojtukiewicz M.Z., Sierko E., Klement P., Rak J. The hemostatic system and angiogenesis in malignancy. Neoplasia. 3:2001;371-384.
38. Maragoudakis M.E., Tsopanoglou N.E., Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem. Soc. Trans. 30:2002;173-177.
39. Huang Y.Q., Li J.J., Hu L., Lee M., Karpatkin S. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts. Thromb. Haemost. 86:2001;1094-1098.
40. Li J.J., Huang Y.Q., Basch R., Karpatkin S. Thrombin induces the release of angiopoietin-1 from platelets. Thromb. Haemost. 85:2001;204-206.
41. Hashida H., Takabayashi A., Adachi M., Imai T., Kondo K., Kohno N., Yamaoka Y., Miyake M. The novel monoclonal antibody MH8-4 inhibiting cell motility recognizes integrin alpha 3: inverse of its expression with metastases in colon cancer. Int. J. Oncol. 18:2001;89-95.
42. Stallmach A., von Lampe B., Matthes H., Bornhoft G., Riecken E.O. Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation. Gut. 33:1992;342-346.
43. Snyder R.D., Pullman J., Carter J.H., Carter H.W., DeAngelo A.B. In vivo administration of dichloroacetic acid suppresses spontaneous apoptosis in murine hepatocytes. Cancer Res. 55:1995;3702-3705.
44. Tong Z., Board P.G., Anders M.W. Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem. J. 331(2):1998;371-374.
45. Tong Z., Board P.G., Anders M.W. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. Chem. Res. Toxicol. 11:1998;1332-1338.
46. Yang H.M., Houser W.H., Davis M.E. Dichloroacetic acid treatment increases hepatic CYP2E1 in male and female rats. Toxicol. Appl. Pharmacol. 141:1996;382-388.
47. Pereira M.A. Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. Fundam. Appl. Toxicol. 31:1996;192-199.
48. Hahnemann B., Salonpaa P., Pasanen M., Maenpaa J., Honkakoski P., Juvonen R., Lang M., Pelkonen O., Raunio H. Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression. Biochem. J. 286:1992;289-294.
49. Lavery D.J., Lopez-Molina L., Margueron R., Fleury-Olela F., Conquet F., Schibler U., Bonfils C. Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP. Mol. Cell Biol. 19:1999;6488-6499.
50. Yokomori N., Nishio K., Aida K., Negishi M. Transcriptional regulation by HNF-4 of the steroid 15 alpha-hydroxylase P450 (Cyp2a-4) gene in mouse liver. J. Steroid Biochem. Mol. Biol. 62:1997;307-314.
51. Takagi H., Aida K., Sohara N., Mori M., Merlino G., Negishi M. Steroid hormone-dependent overexpression of cytochromes P450 2A in liver tumors of TGF alpha transgenic male mice. J. Gastroenterol. 32:1997;708-711.
52. Parrish J.M., Austin E.W., Stevens D.K., Kinder D.H., Bull R.J. Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. Toxicology. 110:1996;103-111.
53. Stacpoole P.W., Henderson G.N., Yan Z., Cornett R., James M.O. Pharmacokinetics, metabolism and toxicology of dichloroacetate. Drug Metab. Rev. 30:1998;499-539.
54. Lingohr M.K., Thrall B.D., Bull R.J. Effects of dichloroacetate (DCA) on serum insulin levels and insulin-controlled signaling proteins in livers of male B6C3F1 mice. Toxicol. Sci. 59:2001;178-184.
55. Hwang J.B., Hernandez J., Leduc R., Frost S.C. Alternative glycosylation of the insulin receptor prevents oligomerization and acquisition of insulin-dependent tyrosine kinase activity. Biochim. Biophys. Acta. 1499:2000;74-84.
56. Shiraishi S., Yokoo H., Kobayashi H., Yanagita T., Uezono Y., Minami S., Takasaki M., Wada A. Post-translational reduction of cell surface expression of insulin receptors by cyclosporin A, FK506 and rapamycin in bovine adrenal chromaffin cells. Neurosci. Lett. 293:2000;211-215.